Exelixis Valuation

EXEL Stock  USD 23.29  0.42  1.84%   
At this time, the firm appears to be undervalued. Exelixis shows a prevailing Real Value of $24.11 per share. The current price of the firm is $23.29. Our model computes the value of Exelixis from reviewing the firm fundamentals such as Shares Outstanding of 294.8 M, profit margin of 0.11 %, and Current Valuation of 6.05 B as well as analyzing its technical indicators and probability of bankruptcy. In general, most investors advise picking up undervalued instruments and discarding overvalued instruments since, at some point, asset prices and their ongoing real values will submerge. Key fundamental drivers impacting Exelixis' valuation include:
Price Book
3.0548
Enterprise Value
B
Enterprise Value Ebitda
31.0806
Price Sales
3.7787
Forward PE
17.6678
Undervalued
Today
23.29
Please note that Exelixis' price fluctuation is very steady at this time. Calculation of the real value of Exelixis is based on 3 months time horizon. Increasing Exelixis' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Exelixis is useful when determining the fair value of the Exelixis stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Exelixis. Since Exelixis is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Exelixis Stock. However, Exelixis' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  23.29 Real  24.11 Target  25.76 Hype  22.85 Naive  22.81
The real value of Exelixis Stock, also known as its intrinsic value, is the underlying worth of Exelixis Company, which is reflected in its stock price. It is based on Exelixis' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Exelixis' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Exelixis' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
24.11
Real Value
25.69
Upside
Estimating the potential upside or downside of Exelixis helps investors to forecast how Exelixis stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Exelixis more accurately as focusing exclusively on Exelixis' fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.110.240.47
Details
Hype
Prediction
LowEstimatedHigh
21.2722.8524.43
Details
Naive
Forecast
LowNext ValueHigh
21.2322.8124.39
Details
21 Analysts
Consensus
LowTarget PriceHigh
23.4425.7628.59
Details
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Exelixis' intrinsic value based on its ongoing forecasts of Exelixis' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Exelixis' closest peers. When choosing an evaluation method for Exelixis, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Exelixis Investments

(317.75 Million)

Exelixis Valuation Trend

Knowing Exelixis' actual value is paramount for traders to make sound investment determinations. Exelixis' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Exelixis' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Exelixis' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Exelixis Market Cap

Exelixis is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 133.33 Billion. Exelixis holds roughly 6.74 Billion in market capitalization claiming about 5% of equities under Health Care industry.
Capitalization  Revenue  Valuation  Workforce  Total debt

Exelixis Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Exelixis's current stock value. Our valuation model uses many indicators to compare Exelixis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Exelixis competition to find correlations between indicators driving Exelixis's intrinsic value. More Info.
Exelixis is rated # 3 in price to earning category among related companies. It is rated below average in price to book category among related companies fabricating about  0.06  of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Exelixis is roughly  15.77 . Price To Book Ratio is expected to rise to 4.24 this year. Comparative valuation analysis is a catch-all model that can be used if you cannot value Exelixis by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Exelixis' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Exelixis' earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Exelixis' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Exelixis and how it compares across the competition.

About Exelixis Valuation

The stock valuation mechanism determines the current worth of Exelixis on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Exelixis. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Exelixis based exclusively on its fundamental and basic technical indicators. By analyzing Exelixis's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Exelixis's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Exelixis. We calculate exposure to Exelixis's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Exelixis's related companies.
Last ReportedProjected for Next Year
Gross Profit1.8 B1.8 B
Pretax Profit Margin 0.20  0.22 
Operating Profit Margin 0.20  0.21 
Net Profit Margin 0.16  0.17 
Gross Profit Margin 0.96  1.14 

8 Steps to conduct Exelixis' Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Exelixis' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Exelixis' valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Exelixis' financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Exelixis' revenue streams: Identify Exelixis' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Exelixis' industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Exelixis' growth potential: Evaluate Exelixis' management, business model, and growth potential.
  • Determine Exelixis' financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Exelixis' estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Exelixis Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Exelixis does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding321.5 M
Quarterly Earnings Growth Y O Y-0.986
Forward Price Earnings17.6678

Exelixis Current Valuation Indicators

Valuation refers to the process of determining the present value of Exelixis and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Exelixis we look at many different elements of the entity such as Exelixis's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Exelixis' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Exelixis' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Exelixis, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Exelixis' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Exelixis' worth.
When determining whether Exelixis is a strong investment it is important to analyze Exelixis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Exelixis' future performance. For an informed investment choice regarding Exelixis Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exelixis. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.
Note that the Exelixis information on this page should be used as a complementary analysis to other Exelixis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for Exelixis Stock analysis

When running Exelixis' price analysis, check to measure Exelixis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Exelixis is operating at the current time. Most of Exelixis' value examination focuses on studying past and present price action to predict the probability of Exelixis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Exelixis' price. Additionally, you may evaluate how the addition of Exelixis to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Is Exelixis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exelixis. If investors know Exelixis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exelixis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.99)
Earnings Share
0.65
Revenue Per Share
5.753
Quarterly Revenue Growth
0.131
Return On Assets
0.0355
The market value of Exelixis is measured differently than its book value, which is the value of Exelixis that is recorded on the company's balance sheet. Investors also form their own opinion of Exelixis' value that differs from its market value or its book value, called intrinsic value, which is Exelixis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exelixis' market value can be influenced by many factors that don't directly affect Exelixis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Exelixis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Exelixis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exelixis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.